Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTEMIS: darTregs for Immunosuppression Withdrawal in Liver Transplant
NCT02474199Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2016
- Primary completion
- Dec 2019
- Modality
- Regulatory T Cells (Tregs), Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of darTreg in Liver transplant rejection, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2016; status: completed.
02
Drugs
darTreg
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02474199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474199.